MULTI-LINK MINI VISION 1007823-18Recalls & reported problems
Abbott Vascular Inc. · MULTI-LINK MINI VISION Coronary Stent and Stent Delivery System 2.50 mm x 18 mm / Rapid-Exchange · Class 3 · Implant
All models of MULTI-LINK MINI VISION (16)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648049521), received between Apr 10, 2017 and Apr 10, 2017 — classified as 1 injury.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Device Dislodged or Dislocated1
- Difficult to Remove1
- Failure to Advance1
- Physical Property Issue1
Patient problems
- Foreign Body In Patient1
- Thrombosis1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryApr 10, 2017Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated; Physical Property Issue
IT WAS REPORTED THAT THE 2.5 X 18 MM MINI VISION STENT DELIVERY SYSTEM WAS PREPARED FOR USE PER INSTRUCTIONS FOR USE (IFU). THE PHYSICIAN COMMENTED THAT THE DEVICE LOOKED DIFFERENT THAN USUAL AND WAS TOLD THAT THE DEVICE WAS PREPARED PER IFU AND NO ISSUES WERE NOTED. THE DEVICE WAS ADVANCED INTO THE PATIENT ANATOMY, VIA BRACHIAL ARTERY ACCESS, AND HAD DIFFICULTY CROSSING. THE DEVICE WAS PULLED BACK AND RESISTANCE WAS NOTED. UPON REMOVAL, IT WAS NOTED THAT THE STENT HAD DISLODGED. THE PROCEDURE WAS COMPLETED WITH IMPLANTATION OF A SECOND MINI VISION, VIA THE FEMORAL ARTERY. POST PROCEDURE, THE PATIENT WAS TAKEN BACK TO INTERVENTIONAL RADIOLOGY, IN ORDER TO RETRIEVE THE DISLODGED STENT. IT WAS NOTED THAT THE VESSEL, WHERE THE DISLODGED STENT REMAINED, HAD THROMBOSED AND TISSUE PLASMINOGEN ACTIVATOR (TPA) WAS ADMINISTERED. THE STENT COULD NOT BE RETRIEVED AND REMAINS IN THE PATIENT ANATOMY. THE PATIENT WAS DISCHARGED TO HOME IN STABLE CONDITION. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Foreign Body In Patient; Thrombosis
MAUDE report 6476291 ↗
Other STENT, CORONARY devices
- WALLSTENT® Endoprosthesis H965403130Boston Scientific Corporation · STENT, CORONARY35 reports
- WALLSTENT® Endoprosthesis H965402130Boston Scientific Corporation · STENT, CORONARY23 reports
- Tryton Side Branch Stent T5-2530-191-USTryton Medical, Inc. · Stent, Coronary1 death22 reports
- WALLSTENT® Endoprosthesis H965403330Boston Scientific Corporation · STENT, CORONARY21 reports
- WALLSTENT® Endoprosthesis H965403320Boston Scientific Corporation · STENT, CORONARY10 reports
- WALLSTENT® Endoprosthesis H965403120Boston Scientific Corporation · STENT, CORONARY9 reports
- PALMAZ Balloon Expandable Stent P308Cordis US Corp. · STENT, CORONARY7 reports
- Cobra PzF 170-03-35024Celonova Biosciences, Inc. · Stent, Coronary7 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page